Impact of a patient decision aid on care among patients with nonvalvular atrial fibrillation: a cluster randomized trial

被引:84
作者
McAlister, FA
Man-Son-Hing, M
Straus, SE
Ghali, WA
Anderson, D
Majumdar, SR
Gibson, P
Cox, JL
Fradette, M
机构
[1] Univ Alberta, Div Gen Internal Med, Edmonton, AB, Canada
[2] Univ Alberta, Epidemiol Coordinating & Res Ctr, Edmonton, AB, Canada
[3] Univ Ottawa, Elisabeth Bruyere Res Inst, Ottawa, ON, Canada
[4] Univ Ottawa, Div Geriatr Med, Ottawa, ON, Canada
[5] Univ Toronto, Div Geriatr, Toronto, ON, Canada
[6] Univ Toronto, Div Gen Internal Med, Toronto, ON, Canada
[7] Univ Calgary, Dept Gen Internal Med, Calgary, AB, Canada
[8] Dalhousie Univ, Dept Med, Halifax, NS, Canada
[9] Capital Hlth, Halifax, NS, Canada
关键词
D O I
10.1503/cmaj.050091
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Too few patients with nonvalvular atrial fibrillation ( NVAF) receive appropriate antithrombotic therapy. We tested the short- term ( primary outcome) and long- term ( secondary outcome) effect of a patient decision aid on the appropriateness of antithrombotic therapy among patients with NVAF. Methods: We conducted a cluster randomized trial with blinded outcome assessment involving 434 NVAF patients from 102 community- based primary care practices. Patients in the intervention group received a self- administered booklet and audiotape decision aid tailored to their personal stroke risk profile. Patients in the control group received usual care. The primary outcome measure was change in antithrombotic therapy at 3 months. Appropriateness of therapy was defined using the American College of Chest Physicians ( ACCP) recommendations. Results: The mean patient age was 72 years, and the median duration of NVAF was 5 years. In the control group, there was a 3% decrease over 3 months in the number of patients receiving therapy appropriate to their risk of stroke ( 40% [ 85/ 215] at baseline v. 37% [ 79/ 215] at 3 months). In the intervention group, the number of patients receiving therapy appropriate to their stroke risk increased by 9% ( 32% [ 69/ 219] at baseline v. 41% [ 89/ 219] at 3 months). Although the proportion of patients whose therapy met the ACCP treatment recommendations did not differ between study arms at baseline ( p = 0.11) or 3 months ( p = 0.44), there was a 12% absolute improvement in the number of patients receiving appropriate care in the intervention group compared with the control group at 3 months ( p = 0.03). The beneficial effect of the decision aid did not persist ( p = 0.44 for differences between study arms after 12 months). Interpretation: There was short- term improvement in the appropriateness of antithrombotic care among patients with NVAF who were exposed to a decision aid, but the improvement did not persist.
引用
收藏
页码:496 / 501
页数:6
相关论文
共 29 条
[11]   Videotape increases parent knowledge about poliovirus vaccines and choices of polio vaccination schedules [J].
Dunn, RA ;
Shenouda, PE ;
Martin, DR ;
Schultz, AJ .
PEDIATRICS, 1998, 102 (02) :e26
[12]   Anticoagulation therapy for stroke prevention in atrial fibrillation - How well do randomized trials translate into clinical practice? [J].
Go, AS ;
Hylek, EM ;
Chang, YC ;
Phillips, KA ;
Henault, LE ;
Capra, AM ;
Jensvold, NG ;
Selby, JV ;
Singer, DE .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (20) :2685-2692
[13]   An interactive computer program can effectively educate patients about genetic testing for breast cancer susceptibility [J].
Green, MJ ;
Biesecker, BB ;
McInerney, AM ;
Mauger, D ;
Fost, N .
AMERICAN JOURNAL OF MEDICAL GENETICS, 2001, 103 (01) :16-23
[14]   Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: A meta-analysis [J].
Hart, RG ;
Benavente, O ;
McBride, R ;
Pearce, LA .
ANNALS OF INTERNAL MEDICINE, 1999, 131 (07) :492-+
[15]   Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing [J].
Lerman, C ;
Biesecker, B ;
Benkendorf, JL ;
Kerner, J ;
GomezCaminero, A ;
Hughes, C ;
Reed, MM .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (02) :148-157
[16]  
Majumdar SR, 2005, PHARMACOEPIDEMIOLOGY, 4TH EDITION, P419
[17]   A patient decision aid regarding antithrombotic therapy for stroke prevention in atrial fibrillation - A randomized controlled trial [J].
Man-Son-Hing, M ;
Laupacis, A ;
O'Connor, AM ;
Biggs, J ;
Drake, E ;
Yetisir, E ;
Hart, RG .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (08) :737-743
[18]  
McAlister FA, 2002, STROKE, V33, P243
[19]   A randomized trial to assess the impact of an antithrombotic decision aid in patients with nonvalvular atrial fibrillation: The DAAFI trial protocol [ISRCTN14429643] [J].
McAlister F.A. ;
Man-Son-Hing M. ;
Straus S.E. ;
Ghali W.A. ;
Gibson P. ;
Anderson D. ;
Cox J. ;
Fradette M. ;
Sackett D. ;
Teo K. ;
Laupacis A. ;
Priest P. ;
Hervas-Malou M. ;
Blitz S. ;
Larson B. ;
Jessup-Yabsley A. ;
Biggs J. ;
Bell N. ;
Bungard I. ;
Marquez C. ;
Quinton S. ;
McNeil A. ;
Lye T. ;
Auer J. ;
Bacskai S. ;
Beaulieau C. ;
Berlie M. ;
Biggs E. ;
Boag P. ;
Bowen D. ;
Brown E. ;
Brisebois J. ;
Buczek M. ;
Bushforth R. ;
Charania H. ;
Cregan T. ;
D'Amico C. ;
Dechesne C. ;
Dy H. ;
Edirisinghe M. ;
Elkin E. ;
Faloon T. ;
Finestone D. ;
Guy D. ;
Hans D. ;
Honsl E. ;
Hughes O. ;
Jaffer S. ;
John R. ;
Jones K. .
BMC Cardiovascular Disorders, 4 (1)
[20]   Randomized, controlled trial of on interactive videodisc decision aid for patients with ischemic heart disease [J].
Morgan, MW ;
Deber, RB ;
Llewellyn-Thomas, HA ;
Gladstone, P ;
Cusimano, RJ ;
O'Rourke, K ;
Tomlinson, G ;
Detsky, AS .
JOURNAL OF GENERAL INTERNAL MEDICINE, 2000, 15 (10) :685-693